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Abstract
The a4 integrin subunit associates with b7 and b1 and plays important roles in immune function and cell trafficking. The
gut-homing receptor a4b7 has been recently described as a new receptor for HIV. Here, we describe polymorphisms of
ITGA4 gene in New World primates (NWP), and tested their impact on the binding to monoclonal antibodies, natural ligands
(MAdCAM and VCAM), and several gp120 HIV-1 envelope proteins. Genomic DNA of NWP specimens comprising all genera
of the group had their exons 5 and 6 (encoding the region of binding to the ligands studied) analyzed. The polymorphisms
found were introduced into an ITGA4 cDNA clone encoding the human a4 subunit. Mutant a4 proteins were co-expressed
with b7 and were tested for binding of mAbs, MAdCAM, VCAM and gp120 of HIV-1, which was compared to the wild-type
(human) a4. Mutant a4 proteins harboring the K201E/I/N substitution had reduced binding of all ligands tested, including
HIV-1 gp120 envelopes. The mAbs found with reduced biding included one from which a clinically-approved drug for the
treatment of neurological disorders has been derived. a4 polymorphisms in other primate species may influence outcomes
in the development and treatment of infectious and autoimmune diseases in humans and in non-human primates.
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Introduction
Integrins are essential molecules involved in a variety of
immunomodulatory functions in vertebrates, including cell
adhesion, cellular trafficking and immune responses [1]. They
function as heterodimeric receptors that mediate adhesion to
immunoglobulin superfamily molecules and to extracellular
matrices. Twenty-four different integrin heterodimers are current-
ly recognized, formed by combination of at least 18 a-subunits and
8 b-subunits, each one encoded by a different gene [2]. Specific
integrin expression is found in distinct cell types and the presence
of integrins on the cell surface plays a key role in the migration of
cells to different tissues. In addition to their physiological role,
integrins are increasingly recognized to function as receptors for
many viruses, including rotaviruses, herpesviruses and retroviruses
such as HIV [3,4,5,6]. Invariably, viruses bind to integrins through
the same domains as their natural ligands, by mimicking
immunoglobulin binding motifs.
The a4 integrin (CD49d) is encoded by the ITGA4 gene (geneID
3676), located in chromosome 2 at 2q31.3. It comprises 28 exons,
spanning over 80 kb. The a4 subunit binds to either b1o rb7
subunits to form heterodimeric integrin receptors [7]. a4 is highly
expressed on T and B lymphocytes, monocytes, natural killer and
dendritic cells [7,8]. In primates, the heterodimer a4b7 acts as a
gut homing receptor, targeting and binding a4b7-expressing cells
to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) on
capillary venules. a4b1, on the other hand, induces mesenchymal
cell migration and B- and T-cell development by binding
preferentially to fibronectin and vascular cell adhesion molecule-
1 (VCAM-1) [1,8]. a4b7 and a4b1 adopt three conformations that
exhibit different affinities for MAdCAM and VCAM: inactive,
intermediate and extended/activated [9]. The conversion between
these forms relies on conformational changes that the heterodimer
is subject to in response to a complex set of signals that includes
ligand binding.
Recently, the gut homing receptor a4b7 has been recognized as
a receptor for HIV-1, a binding governed by a tripeptide in the V2
loop of the viral gp120 that mimics the structure present in the
integrin natural ligands [4]. As a consequence, HIV-1 gp120 binds
to the same integrin domains defined as the target motifs to
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encoded by ITGA4 exons 5 and 6. It has been suggested that such
binding facilitates the targeting of HIV-1-infected T-lymphocytes
to the gut-associated lymphoid tissue (GALT), where a massive
depletion of CD4
+ T-cells occurs, leading to the HIV-1-induced
immune dysfunction observed during virus acute infection [4].
HIV gp120 also appears to bind differently to the distinct
conformational forms of a4b7 [4]. The interaction between
lentiviruses and a4b7 is reiterated in another pathogenic model of
lentiviral infection, that of simian immunodeficiency virus (SIV)-
infected rhesus macaques [11,12,13]. Consistent with this model,
recent evidence has been presented which indicates that blocking
a4b7 during acute infection of rhesus macaques with SIV reduces
plasma- and GALT-associated viral replication [14].
An exception to the Primates order, New World primates
(NWP) are not reported to be infected in natura or in captivity by
SIV. Several host genes encoding proteins that counteract
lentivirus infection, collectively called restriction factors, have
been studied in NWP, and diverse genus- and species-specific
restriction phenotypes have been described for this primate group.
These restriction factors include CCR5 and CXCR4 [15,16,17],
TRIM5a [18,19,20,21,22], members of the APOBEC gene family
[23,24] and tetherin [25]. We hypothesized that genetic
determinants in the ITGA4 gene, translated into nonsynonymous
polymorphisms in the a4 subunit of a4b7, can also contribute to
the plethora of restriction phenotypes that render NWP resistant
to lentiviral infections. With this objective, we analyzed genetic
polymorphisms of ITGA4 in a large, representative collection of
NWP. We found several new ITGA4 variants with synonymous
and non-synonymous substitutions. Functional analyses of some of
these variant a4 integrins indicate impaired affinity to natural
ligands, to a4b7-directed monoclonal antibodies and to various
HIV-1 gp120 molecules. Some of these changes may explain, at
least in part, the restriction of some NWP species to lentivirus
infection. Our study has also provided detailed information on the
interaction between the a4 integrins to their natural ligands as well
as to HIV gp120.
Materials and Methods
Animal sources and genomic DNA
Genomic DNA of 164 samples of New World primates
previously available at the Brazilian Cancer Institute (INCA)
comprising all three Platyrrhini families (Atelidae, Cebidae and
Pitheciidae), 15 genera and 48 different species were analyzed. In
addition, multiple specimens (ranging from 2 to 19) from a single
species were included (Table 1). Original samples have been
previously collected by venous puncture, and all procedures were
carried out following the national guidelines and provisions of
IBAMA (Instituto Brasileiro do Meio Ambiente e dos Recursos
Naturais Renova ´veis, Brazil; permanent license number 11375-1).
PCR amplification and sequencing of ITGA4 gene exons 5
and 6
Genomic DNA was extracted from specimens’ peripheral blood
mononuclear cells using the QIAGEN Genomic DNA extraction kit
(QIAGEN, Chatsworth, CA), according to the manufacturer’s
specifications. A PCR reaction was conducted to amplify a ITGA4
genomic region comprising exons 5 and 6 (with the intervening
intron 5), a fragment of approximately 1,550 bp. Primers were
designed according to the human ITGA4 gene sequence publically
available in the GenBank database (acc. # NW_921585) with the
following sequences: ITGA4-F (sense) 59GTTTAATATTT-
CATTTTA-39 (nucleotides21843–21863) and ITGA4-R (antisense)
59-CAGACATGATGCAGATGTTGCAC-39 (nts 23374–23394).
PCR conditions were inthe presenceof100–200 ngDNA, 5 ml1 0 X
PCR buffer, 0.4 ml2 5m Md N T Pm i x ,2 5p m o lo fe a c hp r i m e r ,2ml
of 25 mM MgCl2 and 0.4 ml of 5 UI/ ml Taq Platinum DNA
polymerase (Life Technologies, Carlsbad, CA). Reactions were
carried out in a VeritiH Thermal Cycler (Applied Biosystems Life
Technologies) with an initial denaturing step of 94uCf o r2m i n ,
followed by 35 cycles of 94uC for 30 sec, 46uC for 30 sec and 72uC
for 2 min. A final cycle of extension at 72uC for 8 min followed each
reaction,to complete unfinished DNA strands. A second PCR (semi-
nested) was then carried out to individually amplify exons 5 and 6.
For exon 5, primers ITGA4-F (sense) and ITGA4-RI (antisense; 59-
GGTACTATAAAAATTGACAAAC-39; nts 22027-22049) were
used. For exon6, ITGA4-FI (sense; 59-CAGGATTTAATTGT-
GATGGG-39; nts 23241-23260) and ITGA-R (antisense) were
employed. PCR reactions were carried out with 5 ml of the initial
PCR reaction described above and under the same conditions, with
the exception of the extension time, set to 30 sec.
PCR products corresponding to exons 5 and 6 of individual
specimens were purified with the Illustra
TM GFX PCR DNA
and Gel Band Purification kit (GE HealthCare, Sa ˜o Paulo,
Brazil), quantified and sequenced using the Big Dye v.3.1 kit
(Life Technologies, Carlsbad, USA). Sequencing primers used
were the same as in the 2
nd round PCR reaction described
above. DNA sequencing was carried out in an automated ABI
3130XL Genetic Analyzer (Life Technologies) and manually
edited with the software SeqMan v7.0 (DNASTAR Inc,
Madison, USA). Sequences were then aligned using BioEdit
v7.0 [26], and a consensus sequence for each species was
generated. For means of comparison, ITGA4 sequences from
human (Homo sapiens), chimpanzee (Pan troglodytes), rhesus
macaque (Macaca mulatta), mouse (Mus musculus), horse (Equus
caballus), cow (Bos taurus) and African green monkey (Chlorocebus
sp.), retrieved from GenBank, were also included in the
alignment. Deduced amino acid sequences were generated from
each DNA consensus sequence andc o m p a r e db e t w e e ns p e c i e s .
Amino acid substitutions characteristic of each neotropical
primate genus were placed in the currently accepted Platyrrhini
phylogenetic tree (Figure 1) to estimate their appearance during
Platyrrhini radiation.
All DNA sequences generated in this work were submitted to
the GenBank nucleotide sequence database and were assigned the
accession numbers JF938225 to JF938528.
Site-directed mutagenesis and expression of mutated a4
subunits
Non-synonymous polymorphisms found in the newly charac-
terized ITGA4 alleles of NWP were inserted into a mammalian
expression plasmid containing the cDNA encoding the reference
published human ITGA4 gene, in an individual fashion or in
different double, triple or quadruple combinations, that included
the five polymorphisms found in some specimens. Site-directed
mutants were constructed using the QuickChange
TM Site-
directed mutagenesis kit (Agilent Technologies, Inc., Santa Clara,
CA), according to the fabricant’s specifications. A complete list of
the mutants generated in this study, and the representative
species in which the polymorphisms were observed, is found in
Table 2. Table S1 depicts all primers used in the site-directed
mutagenesis experiments, together with the annealing tempera-
tures employed. Mutant plasmids were scaled and all mutations
were further confirmed by DNA sequencing to confirm the
presence of the desired mutation(s) and the lack of additional
changes.
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293T cells [27] were maintained in DMEM supplemented with
10% FBS and 2% penicillin/streptomycin (all reagents from Life
Technologies) in 75 cm
2 cell culture flasks at 37uC in a 5% CO2
incubator. On the day prior to transfections, 5610
5 cells were split
into 100 mm
2 tissue culture plates (Tecno Plastic Products AG,
Trasadingen, Switzerland) with 10 ml of supplemented DMEM,
and incubated overnight as above. On the following day, plates
were transfected (PolyFectH Transfection Reagent (QIAGEN,
Valencia, CA) in replicates with an expression plasmid harboring a
cDNA copy of the wild-type b7 subunit [4], together with one of
the a4 subunit mutants. Co-transfection of wild-type a4 and b7
was carried out in parallel as a control. At 48 h post-transfection,
cells were harvested with versene, rinsed thoroughly and stained
for flow cytometry analysis.
a4b7 binding efficiencies of antibodies / ligands
Cells were stained with phycoerythrin-conjugated monoclonal
antibodies (mAbs) using standard procedures as described in
Arthos et al. [4] mAbs used were 7.2, 2b4 and HP2/1 (anti-a4);
FIB 504 (anti-b7); ACT-1 (anti-a4b7 heterodimer); all obtained
from Serotek (Oxford, UK) or Millipore (Billerica, MA), except for
ACT-1, available at the NIAID AIDS Reagent Program. The 7.2
anti-a4 binds to a distal epitope relative to the natural ligand
binding site on a4 [10], and was thus used a control for the levels
of both mutant and wild-type a4 expression on the cell surface.
Cells were also stained with recombinant MAdCAM- and VCAM-
Ig fusion proteins (R&D Systems, Minneapolis, MN), as described
in Arthos et al. [4] Finally, a4b7-transfected cells were also tested
for HIV-1 gp120 binding using recombinant gp120 proteins
biotinylated by amine-coupled chemistry as previously detailed
[4]. The following recombinant viral gp120’s were tested:
Q23.335 (subtype A; GenBank acc. # DQ136335), 93MW959
(subtype C; GenBank acc. # U08453), and a derivative of AN1
(subtype B, sequence available at http://ubik.mullins.microbiol.
washington.edu/HIV/ Doria-Rose2005/) harboring a N201Q
substitution that enhances binding to a4b7 [28]. All gp120’s tested
were CCR5-tropic. Binding efficiencies (BE) of antibodies and
recombinant proteins to a4b7-transfected cells were represented as
the ratio of the MFI of a4b7-transfected cells compared to the
MFI of mock-transfected cells. Whenever multiple experiments
were available, data were represented as the average BE of
different experiments, and the associated standard errors are
provided. For these cases, the BE to different a4 variants were
compared with Student’s t tests and p-values #0.05 were
considered significant.
Table 1. New World primate specimens analyzed in this
study.
Species name Common name
No. of
specimens
Family Atelidae
Alouatta belzebul red-handed howler monkey 6
Alouatta caraya black howler monkey 5
Alouatta guariba red-and-black howler monkey 2
Alouatta seniculus red howler monkey 2
Ateles paniscus black spider monkey 1
Family Cebidae
Brachyteles arachnoides southern muriqui 3
Aotus sp. owl monkey 6
Aotus azarae southern owl monkey 20
Aotus infulatus feline night monkey 1
Callimico goeldii Goeldi’s marmoset 3
Callithrix aurita white-eared marmoset 2
Callithrix geoffroyi Geoffroy’s marmoset 3
Callithrix jacchus white-tufted-ear marmoset 2
Callithrix kuhlii wied’s marmoset 3
Callithrix penicillata black-pencilled marmoset 4
Cebuella pygmaea pygmy marmoset 2
Cebus sp. capuchin monkey 6
Cebus albifrons white-fronted capuchin 5
Cebus apella brown-capped capuchin 19
Cebus capucinus white-faced sapajou 1
Cebus cay hooded capuchin 1
Cebus olivaceus nigrivittatus weeper capuchin 5
Cebus xanthosternos yellow-breasted capuchin 5
Leontophitecus chrysomelas golden-headed lion tamarin 4
Leontophitecus chrysopygus gold-and-black lion tamarin 3
Leontophitecus rosalia golden lion tamarin 3
Mico argentata silvery marmoset 5
Mico emiliae snethlage’s marmoset 6
Mico humeralifer tassel-eared marmoset 3
Mico melanura black-tailed marmoset 2
Saguinus bicolor pied bare-faced tamarin 1
Saguinus fuscicollis brown-headed tamarin 2
Saguinus imperator emperor tamarin 3
Saguinus martinsi Martin’s tamarin 1
Saguinus midas golden-handed tamarin 3
Saguinus mystax moustached tamarin 2
Saguinus niger black-handed tamarin 1
Saguinus oedipus cotton-top tamarin 1
Saimiri sp. squirrel monkeys 4
Family Pitheciidae
Cacajao melanocephalus black-headed uakari 3
Callicebus sp. titi monkeys 2
Callicebus coimbrai Coimbra-filho’s titi monkey 1
Callicebus donacophilus bolivian titi 1
Callicebus hoffmansi Hoffmann’s titi 1
Callicebus moloch dusky titi monkey 3
Species name Common name
No. of
specimens
Callicebus nigrifrons black-fronted titi monkey 3
Callicebus personatus masked titi 3
Chiropotes sp. bearded saki 3
Chiropotes albinasus red-nosed bearded saki 1
Chiropotes israelita brown-backed bearded saki 1
Chiropotes satanas black-bearded saki 1
doi:10.1371/journal.pone.0024461.t001
Table 1. Cont.
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Analysis of ITGA4 genotypes in New World primate
specimens
The analysis of ITGA4 gene exons 5 and 6 from over a hundred
specimens of neotropical primate species showed a multitude of
different genotypes. Of note, in no case were the exon 5 and 6
sequences obtained from these specimens identical to that of either
human ITGA4 (GenBank acc. # NM_000885) or the Old World
primate specimens we analyzed. Numerous non-synonymous
changes were found in distinct specimens, but most changes
occurred at 5 codons of the sequences analyzed: codons 154 and
161 in exon 5, and codons 197, 201 and 208 in exon 6 (codon
numbering refers to the mature a4 protein, after processing of its
signal peptide) (Figure 2 and Table 2). At these positions, the
major polymorphisms found were N161H, Y154H, I197M,
K201N/I/E and K208E/R/G. Most polymorphisms were found
individually or in combination within specific clades of NWP
(genera or families; Table 2), characterizing ancestral polymor-
phism arisen during Platyrrhini radiation. Based on a recently
updated Platyrrhini phylogeny [29], we hypothesize that these
variants emerged from a common ancestral ITGA4 during
Platyrrhini evolution (Figure 1).
The nature of the amino acid changes characteristic of ITGA4
polymorphisms varied significantly. Whereas both substitutions in
the coding sequence of exon 5 (positions 154 and 161) and the
I197M substitution in exon 6 did not involve a change the
electrostatic charge, K201I and K208G in exon 6 did involve the
loss of a positively-charged amino acid, resulting in change in the
local electrostatic environment in this region of a4.
Binding properties of NWP a4 variants to monoclonal
antibodies and natural ligands
Based on the polymorphisms found in ITGA4 genes from NWP,
we determined to dissect the relative impact of each a4 amino acid
change on the binding efficiencies of a4-directed monoclonal
antibodies and of a4 natural ligands. To pursue this, we
constructed a panel of single and multiple mutant a4 variants,
with different combinations of the polymorphisms displayed by
NWP specimens (Table 2), and tested their ability to bind to those
molecules. Figure 3 depicts the results of the binding assays to anti-
a4 mAbs 2b4 and HP2/1. A plethora of different binding
efficiencies (BE) were observed when testing all a4 mutants, but, in
general the effects of these mutants were similar for both 2b4 and
HP2/1 (compare Figures 3A and B). This is consistent with the
idea that both mAbs target closely space epitopes in the same
region of a4. It is noteworthy that this is the same region of a4 that
mediates binding to the a4b7 natural ligands MAdCAM-1 and
VCAM-1.[10] The anti-a4 antibody 7.2 (which targets a distal
region of a4) [10] and the anti-b7 antibody, FIB504, did not show
differences in binding to a4b7 molecules that incorporated the
NWP polymorphisms relative to wild-type a4b7 (data not shown).
Most strikingly, all single and multiple mutants containing changes
at codon 201 (highlighted in both Figures 3A and B), irrespective
of the amino acid residue change, had a strongly reduced binding
to both HP2/1 and 2b4. Substitution with either non-polar or
polar (negative) amino acid residues disrupted binding of both
mAbs. These results suggest that residue 201 plays a critical role in
the binding of both of these antibodies to a4. We carried out in
triplicate experiments comparing the wild-type human ITGA4
gene with the quintuple mutant Y154H/N161H/I197M/ K201I/
K208G, which contains the most frequent polymorphisms found
among Platyrrhini, and is characteristic of the Callithrix, Cebuella
and Mico genera. As depicted in Figure 3C, the BE of mAbs 2b4,
HP2/1 (both anti-a4), and of ACT-1 (anti-a4b7) to this mutant
a4b7 was significantly reduced when compared to wild-type a4b7.
Again, no differences in binding efficiencies were observed for the
anti-a4 7.2 and the anti-b7 FIB504 antibodies (Figure 3C). From
the 7.2 and FIB504 results we can conclude that mutant and wild
type heterodimers were expressed at similar levels in our system,
and therefore the differences observed are rather explained by
distinct differences in affinities of the a4 variants for 2b4 and
HP2/1.
The quintuple mutant was also compared with the human a4
in regard to the binding to a4b7 natural ligands, VCAM and
MAdCAM. 293T cells expressing recombinant a4b7 proteins
were incubated with biotinylated VCAM- or MAdCAM-Ig fusion
proteins and their binding was monitored by flow cytometry. We
have conducted these assays in two different conditions, in the
presence of a buffer containing Mn
2+ or Mg
2+.W h i l eM n
2+
increases the steady-state affinity of the natural ligands VCAM
and MAdCAM to a4b7 [30], Mg
2+ may better mimic in vivo
physiological conditions. As expected, there was a sharp decrease
in VCAM interactions with both wild-type and a4 variant when
tested in the presence of Mg
2+ at different concentrations (from
0.25 to 2 mg; compare Figures 4A and B) relative to binding in
the presence of Mn
2+, consistent with the idea that in the
presence of Mg
2+, a4b7-ligand interactions are less stable and
exhibit a lower overall affinity [30]. Strikingly, the magnitude of
this decrease was much higher for the mutant a4b7 compared to
the wild-type human counterpart (Figure 4B). This demonstrates
that the polymorphisms present in the mutant a4b7h a v ea
significant impact on VCAM binding under physiological
conditions. Interestingly, MAdCAM did not show the same
pattern. Although MadCAM-Ig showed reduced binding to a4b7
Figure 1. Representation of the likely emergence of a4 amino
acid substitutions encoded by ITGA4 exons 5 and 6 across
neotropical primate radiation. The consensus amino acid sequence
of the Platyrrhini group was used as the ancestral root of the tree, and
residue replacements refer to that sequence. Each replacement had its
emergence estimated and placed into the most updated Platyrrhini
phylogeny according to Perelman et al. [29].
doi:10.1371/journal.pone.0024461.g001
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2+ compared to Mn
2+ (compare Figures 4C
and D), the relative effect of the mutations was less pronounced.
This is consistent with the notion that MAdCAM, because it is
able to engage both the intermediate- and high-affinity
conformations of a4b7, is less sensitive to changes mediated by
the polymorphisms described in this report. Overall, these
experiments corroborate those conducted with the monoclonal
antibodies, indicating that the polymorphisms we observed in
NWP localize to a functionally relevant domain of a4, and
therefore have the potential to disrupt the interaction between
a4b7 with its natural ligands [10].
Binding properties of NWP a4 variants to HIV-1 gp120
We wanted next to test the ability of neotropical primate a4b7
proteins to bind gp120 molecules from diverse HIV-1 reference
and clinical isolates of different genetic subtypes. Recombinant
gp120 s were expressed and conjugated to biotin [4], and tested
for binding into mutant or human a4b7-expressing 293T cells.
Figure 5 depicts BE’s of two gp120 s belonging to distinct HIV-1
subtypes (B and C) to the quintuple mutant or to the human a4
allele. The mutant integrin showed slightly reduced binding to
both gp120 molecules at two different concentrations in a dose-
dependent fashion when compared to the human protein.
Although differences in binding of gp120 were observed for the
a4 alleles, they were modest compared to those seen for
monoclonal antibodies and natural ligands such as VCAM and
MAdCAM. This suggests that the binding site of gp120 to a4b7,
although similar, is not identical to that of MadCAM and
VCAM, and might be determined by additional or more complex
protein interactions. The results presented here suggest that HIV-
1 viruses of different subtypes have moderately reduced affinity to
a4b7 from neotropical primates compared to the human
counterpart.
Discussion
In this study, we have provided evidence that different alleles of
ITGA4 gene, encoding for the a4 subunit of a4b7 integrin in
primates, have disparate abilities to bind to a4b7 natural ligands,
anti-a4b7 monoclonal antibodies, and to lentiviral gp120 envelope
proteins. Such differences in binding appear to be governed by
amino acid residue changes in the a4 protein sequences, which
have arisen and have been fixed during primate evolution.
A multitude of ITGA4 genotypes were found by sequencing
exons 5 and 6 of the gene in neotropical primates. This region of
the gene was chosen in view of its well described functional
importance in mediating the binding of a4b7 to its natural ligands
VCAM and MAdCAM [10], as well to certain monoclonal
antibodies [10] and to the gp120 envelope protein of HIV-1 [4].
Most of the changes observed appeared to be lineage-specific,
being characteristic of distinct Platyrrhini species, genera or
families. In general, these polymorphisms appeared to follow the
radiation of this primate group, and their emergence could be
traced in the phylogeny of the infraorder (Figure 1). Whereas most
of the amino acid changes observed were conservative, several
resulted in a change of local protein net charge and might have a
significant influence on structure. This was the case of the
K201N/I/E and K208E/G substitutions, found in many distinct
genera of NWP.
The analysis of each polymorphism on an individual basis, as
well as in combinations of two, three, four and five changes, has
lead us to dissect their particular role on the binding of mAbs,
natural ligands (VCAM and MAdCAM) and HIV-1 gp120
proteins to a4b7. As a consequence, we were able to pinpoint
the specific role of residue 201 of a4 on the binding of all these
molecules. All mutants harboring non-conservative changes at that
a4 codon, either alone or in combination with other polymor-
phisms, showed reduced affinity to some or all of the molecules
Table 2. Single and multiple a4 mutants generated in this study.
MUTANTS a4 AMINO ACID POSITION(S) NWP genus or family observed
Single ITGA4 Exon 5 Y154H Alouatta
N161H Brachyteles, Aotus
ITGA4 Exon 6 K201I Callithrix, Mico
K201E Cebus
K201N Alouatta, Ateles, Brachyteles
K208E Alouatta, Cebus
K208G Callithrix, Cebuella, Leontopithecus, Mico,
Callicebus
Q211R Aotus
Double Y154H / N161H Cebidae, Chiropotes
Y154H / K208N Alouatta
N161H / K208I Callithrix, Mico
N161H / K208R Aotus, Chiropotes, Pithecia
K201N / K208E Atelidae
Triple Y154H / N161H / K208I Callithrix, Cebuella, Mico
Y154H / N161H / K208E Cebus
Y154H / K201N / K208E Alouatta
N161H / K201N / K208E Ateles, Brachyteles
Quadruple Y154H / N161H / I197M / K201I Callithrix, Cebuella, Mico
Quintuple Y154H / N161H / I197M / K201I / K208G Callithrix, Cebuella, Mico
doi:10.1371/journal.pone.0024461.t002
Polymorphisms in a4 of Neotropical Primates
PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e24461tested. These included mutants with changes of the original lysine
residue found in humans to an isoleucine, an asparagine or a
glutamic acid, found in distinct NWP genera.
We have observed varying effects of the a4 polymorphisms
when assessing binding of different ligands, such as monoclonal
antibodies, natural ligands (VCAM and MAdCAM) and HIV-1
Figure 2. Amino acid alignment of the predicted sequences encoded by ITGA4 exons 5 (left) and 6 (right) of representative species
of neotropical primates. Sequences of each species represent a consensus from 2-19 individual specimens sequenced in this study. Residue
numbering corresponds to that of the mature a4 subunit protein, after cleavage of the signal peptide. Dots represent identities. Numbers before
species’ names depict Platyrrhini families as follows: 1- Atelidae; 2- Cebidae; 3- Pitheciidae (as proposed by Schneider et al. [38]). For means of
comparison, ITGA4 sequences from human (Homo sapiens), chimpanzee (Pan troglodytes), rhesus macaque (Macaca mulatta), mouse (Mus musculus),
horse (Equus caballus), cow (Bos taurus) and African green monkey (Chlorocebus sp.) are shown at the top of the alignment.
doi:10.1371/journal.pone.0024461.g002
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PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24461gp120 molecules. The most dramatic effects on binding were seen
for the mAbs that target the functional motifs of a4. Of note, a
significant obliteration was observed for HP2/1 binding, an
antibody that was used as a basis for the development of
natalizumab, a clinically approved and widely used drug for the
treatment of neurodegenerative disorders such as multiple sclerosis
[31,32], and under clinical trials for Crohn’s disease and other
autoimmune conditions [33,34]. Although we have not yet
identified a similar polymorphism in human a4, we can envisage
a scenario in which particular ITGA4 polymorphisms in humans
might negatively impact the efficacy of natalizumab for treating
neurological disorders as well as other autoimmune diseases.
We have also found pronounced effects of VCAM binding to the
mutant a4b7, particularly when our assay conditions mimicked
physiological conditions such that a significant fraction of a4b7w a s
presented on the cell surface in an intermediate affinity conforma-
tion. Under these conditions, VCAM binding to a4 variants was
completely disrupted. This observation suggests that these variants
could hold the potential to compromise the biological function of
a4b7 and a4b1 integrins. It will be of interest to assess certain
immunological processes, including leucocyte trafficking, the
formation of immunological synapses and cellular immune
responses [35] in neotropical primates bearing these polymor-
phisms. Additionally, the study of polymorphisms in VCAM and
MAdCAM present in those animals is also worthwhile, since
compensatory substitutions in those proteins may have arisen
during NWP evolution to counteract the observed variations in a4.
A mutant a4b7 carrying K201N/I/E, again alone or in
combination with other a4b7 polymorphisms, also showed
reduced affinity to HIV-1 gp120 proteins of different subtypes.
Although the changes in binding to the mutant a4b7 were the
most modest observed, in our preliminary analyses we only tested
gp120 binding in the context of high a4b7 activation (in the
presence of Mn
2+). It is possible that under more physiological
conditions (Mg
2+), such reduced binding phenotype is even more
pronounced, as it has been observed for VCAM binding.
Moreover, we have only tested a limited number of gp120
molecules, and the reactivity of gp120 s for a4b7 varies over a
wide range [28], so that the influence of the a4 polymorphisms
may be different with other gp120 s. Further studies are needed to
address this issue. Finally, it is worth mentioning that our test only
assesses an in vitro binding ability, and it is conceivable that under a
Figure 3. Binding efficiencies (BE) of different a4b7 molecules composed of distinct a4 mutants to monoclonal antibodies against
a4, b7 or the a4b7 heterodimer. Binding efficiency is determined by the ratio between the mean fluorescence of antibody binding to each a4
molecule and of the binding in a mock-transfected cell culture (see Materials and Methods for details). Dark gray bars represent binding to the human
(wild type) a4 clone, whereas light gray bars are those of binding to the different a4 mutants (as shown in the x-axis). a4 mutants which included
substitutions at codon 201 are boxed. A, binding of anti-a4 2b4 antibody. B, binding of anti-a4 HP2/1 antibody. C, BE of different anti-a4 and b7
antibodies to the human a4 and the quintuple a4 mutant (5 aa mut). Bars represent the range of standard errors deduced from triplicate
experiments. p-values of Student’s t tests are shown above each comparison. NS, non-significant (. 0.05).
doi:10.1371/journal.pone.0024461.g003
Figure 4. Binding efficiencies (BE) of VCAM (A and B) and MAdCAM (C and D) to the human a4 and the quintuple a4 mutant (5 aa
mut) in the presence of Mn
2+ (A and C) and Mg
2+ (B and D). Ligands were tested at different amounts (0.25 to 2 mg).
doi:10.1371/journal.pone.0024461.g004
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replication, the differences observed may indeed relate to more
pronounced effects on HIV acquisition or on disease progression.
We are just starting to unveil the molecular interactions between
gp120 and a4b7, as it may be as complex as the interaction with
natural ligands MAdCAM and VCAM [36]. Additional studies
characterizing such interaction are ongoing.
We hypothesize that a4b7 may be considered an additional
factor restricting lentiviral infections in neotropical primates,
similarly to what has been described for other lentiviral interacting
cellular proteins such as the chemokine receptors CCR5 and
CXCR4 [16,17], TRIM5a [19,20,22], the APOBEC proteins
[23,24] and tetherin [25]. In fact, the reduction of HIV-1 gp120
binding to a4b7 harboring K201E/I/N, in which the substitution
of a positively-charged amino acid for a neutral or even negatively
charged residue occurs, can be mechanistically compared to the
binding of gp120 to the coreceptors CCR5 or CXCR4 through its
V3 loop. In that instance, the net charge of amino acids 11 and 25
of the V3 loop sequence determine a higher affinity of the protein
to either CXCR4 (when the net charge is positive) or to CCR5
(when it is negative), in a phenomenon often referred to as the
‘‘11/25 rule’’ [37]. We hypothesize that in the interaction studied
herein, that of HIV-1 gp120 binding to a4b7, the net charge of
a4b7 residue 201 may also be crucial for the binding of the viral
envelope protein to this newly characterized receptor. Further
studies are necessary to evaluate the relative binding efficiencies of
gp120 to distinct NWP a4 variants carrying distinct amino acid
residues at position 201 (see Figure 2 for details).
A multitude of NWP ITGA4 phenotypes may be extrapolated
from their amino acid diversity. Similar disparities in lentivirus
restriction phenotypes have been described in NWP for other
restriction factors such as APOBEC3, TRIM5a and tetherin
proteins [19,21,24,25]. As a result, NWP cells may modulate viral
restriction activities through a complex balance of different protein
factors. Of note, owl monkeys (Aotus) have been shown to carry a
TRIM-Cyp fusion protein that potently restricts HIV-1 [21]. On
the other hand, these monkeys possess a polymorphism in tetherin
which renders it inactive against HIV-1 [25]. In our study, owl
monkeys were shown to harbor a minority variant a4 protein
similar to the human counterpart (harboring a lysine at residue
201). We can depict a scenario in which different primates have
developed alternative strategies for counteracting retroviral
infections. The antiviral activity of other NWP carrying a lysine
at that position (such as Leontopithecus, Saguinus and members of the
Piithecidae family) is warranted further investigation.
A relatively high genetic diversity was found in the ITGA4 gene
of neotropical primates, with some alleles displaying reduced
binding to mAbs, natural ligands and HIV-1 gp120. The existence
of ITGA4 polymorphisms in other primate groups, including those
of African and Asian origin, is anticipated. Therefore, it is
conceivable that ITGA4 polymorphisms in primate species which
are susceptible to, or even natural reservoirs of lentiviral infections
(such as those carried out by SIV or HIV) display a multitude of
lentivirus restriction phenotypes. Clinical and laboratory outcomes
such as lentivirus acquisition, resistance to disease, disease
progression, control of viremia and CD4
+ T-cell depletion are
among the phenomena that may be influenced by ITGA4
polymorphisms in those primate species, including humans, and
their study is warranted further attention. Moreover, additional
studies are required to fully appreciate the consequences of ITGA4
polymorphisms in the development and treatment of infectious
and autoimmune diseases in humans and in their non-human
primate models.
Supporting Information
Table S1 List of primers used for the construction of
mutant a4 clones.
(DOC)
Acknowledgments
We are indebted to the personnel of Dr. James Arthos’ laboratory for
technical training of MDC and SHH during their training visit at the
Laboratory of Immune Regulation at the NIAID, NIH. We also thank Dr.
Cibele Bonvicino and Dr. Miguel Moreira (INCA) for making available
their NWP genomic DNA collection.
Author Contributions
Conceived and designed the experiments: EAS CC ESM JAA MAS.
Performed the experiments: MD SHH EAS. Analyzed the data: MD SHH
EAS ESM JAA MAS. Contributed reagents/materials/analysis tools: EAS
HNS JAA MAS. Wrote the paper: MD ESM JAA MAS.
Figure 5. Binding efficiencies (BE) of different recombinant HIV-1 gp120 molecules at different amounts to the human a4 and the
quintuple a4 mutant (5 aa mut). gp120 molecules tested were A, AN1 N201Q, subtype B isolate AN1 with a substitution at codon 201 [28]; B,
93MW959, subtype C reference isolate from Malawi (GenBank acc. no. AY713413).
doi:10.1371/journal.pone.0024461.g005
Polymorphisms in a4 of Neotropical Primates
PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e24461References
1. Mittelbrunn M, Molina A, Escribese MM, Yanez-Mo M, Escudero E, et al.
(2004) VLA-4 integrin concentrates at the peripheral supramolecular activation
complex of the immune synapse and drives T helper 1 responses. Proc Natl Acad
Sci U S A 101: 11058–11063.
2. Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: biological implications
and therapeutic opportunities. Nat Rev Cancer 10: 9–22.
3. Triantafilou K, Takada Y, Triantafilou M (2001) Mechanisms of integrin-
mediated virus attachment and internalization process. Crit Rev Immunol 21:
311–322.
4. Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, et al. (2008) HIV-1
envelope protein binds to and signals through integrin alpha4beta7, the gut
mucosal homing receptor for peripheral T cells. Nat Immunol 9: 301–309.
5. Graham KL, Fleming FE, Halasz P, Hewish MJ, Nagesha HS, et al. (2005)
Rotaviruses interact with alpha4beta7 and alpha4beta1 integrins by binding the
same integrin domains as natural ligands. J Gen Virol 86: 3397–3408.
6. Dorner M, Zucol F, Alessi D, Haerle SK, Bossart W, et al. (2010) beta1 integrin
expression increases susceptibility of memory B cells to Epstein-Barr virus
infection. J Virol 84: 6667–6677.
7. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell
110: 673–687.
8. Pender SL, Salmela MT, Monteleone G, Schnapp D, McKenzie C, et al. (2000)
Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells
selectively Up-regulates membrane type-1 matrix metalloproteinase and confers
a migratory phenotype. Am J Pathol 157: 1955–1962.
9. Pulido R, Elices MJ, Campanero MR, Osborn L, Schiffer S, et al. (1991)
Functional evidence for three distinct and independently inhibitable adhesion
activities mediated by the human integrin VLA-4. Correlation with distinct
alpha 4 epitopes. J Biol Chem 266: 10241–10245.
10. Schiffer SG, Hemler ME, Lobb RR, Tizard R, Osborn L (1995) Molecular
mapping of functional antibody binding sites of alpha 4 integrin. J Biol Chem
270: 14270–14273.
11. Budde ML, Lhost JJ, Dudley DM, Rakasz EG, O’Connor DH (2010) Integrin
alpha4beta7 is downregulated on the surfaces of simian immunodeficiency virus
SIVmac239-infected cells. J Virol 84: 6344–6351.
12. Kader M, Bixler S, Roederer M, Veazey R, Mattapallil JJ (2009) CD4 T cell
subsets in the mucosa are CD28+Ki-67-HLA-DR-CD69+ but show differential
infection based on alpha4beta7 receptor expression during acute SIV infection.
J Med Primatol 38 Suppl 1: 24–31.
13. Reeves RK, Evans TI, Gillis J, Johnson RP (2010) Simian immunodeficiency
virus infection induces expansion of alpha4beta7+ and cytotoxic CD56+ NK
cells. J Virol 84: 8959–8963.
14. Ansari AA, Reimann KA, Mayne AE, Takahashi Y, Stephenson ST, et al.
(2011) Blocking of {alpha}4{beta}7 Gut-Homing Integrin during Acute
Infection Leads to Decreased Plasma and Gastrointestinal Tissue Viral Loads
in Simian Immunodeficiency Virus-Infected Rhesus Macaques. J Immunol 186:
1044–1059.
15. Mummidi S, Bamshad M, Ahuja SS, Gonzalez E, Feuillet PM, et al. (2000)
Evolution of human and non-human primate CC chemokine receptor 5 gene
and mRNA. Potential roles for haplotype and mRNA diversity, differential
haplotype-specific transcriptional activity, and altered transcription factor
binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian
immunodeficiency virus. J Biol Chem 275: 18946–18961.
16. Ribeiro IP, Schrago CG, Soares EA, Pissinatti A, Seuanez HN, et al. (2005)
CCR5 chemokine receptor gene evolution in New World monkeys (Platyrrhini,
Primates): implication on resistance to lentiviruses. Infect Genet Evol 5:
271–280.
17. Zubair S, Metzenberg S (2000) CXCR4 homologues of gibbon ape, African
green monkey, squirrel monkey, and cotton-top marmoset. AIDS Res Hum
Retroviruses 16: 1179–1182.
18. Maillard PV, Ecco G, Ortiz M, Trono D (2010) The specificity of TRIM5
alpha-mediated restriction is influenced by its coiled-coil domain. J Virol 84:
5790–5801.
19. Pacheco B, Finzi A, McGee-Estrada K, Sodroski J (2010) Species-specific
inhibition of foamy viruses from South American monkeys by New World
Monkey TRIM5{alpha} proteins. J Virol 84: 4095–4099.
20. Ribeiro IP, Menezes AN, Moreira MA, Bonvicino CR, Seuanez HN, et al.
(2005) Evolution of cyclophilin A and TRIMCyp retrotransposition in New
World primates. J Virol 79: 14998–15003.
21. Sayah DM, Sokolskaja E, Berthoux L, Luban J (2004) Cyclophilin A
retrotransposition into TRIM5 explains owl monkey resistance to HIV-1.
Nature 430: 569–573.
22. Soares EA, Menezes AN, Schrago CG, Moreira MA, Bonvicino CR, et al.
(2010) Evolution of TRIM5alpha B30.2 (SPRY) domain in New World
primates. Infect Genet Evol 10: 246–253.
23. Perez-Caballero D, Soll SJ, Bieniasz PD (2008) Evidence for restriction of
ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha
proteins. PLoS Pathog 4: e1000181.
24. Sawyer SL, Emerman M, Malik HS (2004) Ancient adaptive evolution of the
primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol 2: E275.
25. Wong SK, Connole M, Sullivan JS, Choe H, Carville A, et al. (2009) A New
World primate deficient in tetherin-mediated restriction of human immunode-
ficiency virus type 1. J Virol 83: 8771–8780.
26. Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and
analysis program for Windows 95/98/NT. Nuclei Acids Symposium Series 41:
95–98.
27. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of
mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell
Biol 7: 379–387.
28. Nawaz F, Cicala C, van Ryk D, Block KE, Jelicic K, et al. (2011) The Genotype
of Early-Transmitting HIV gp120s Promotes High a4b7–Reactivity, Revealing
a4b7+/CD4+ T cells As Key Targets in Mucosal Transmission. PLoS Pathog 7:
e1001301.
29. Perelman P, Johnson W, Roos C, Seuanez HN, Horvath JE, et al. (2011) A
molecular phylogeny of living primates. PLoS Genetics 7: e1001342.
30. Day ES, Osborn L, Whitty A (2002) Effect of divalent cations on the affinity and
selectivity of alpha4 integrins towards the integrin ligands vascular cell adhesion
molecule-1 and mucosal addressin cell adhesion molecule-1: Ca2+ activation of
integrin alpha4beta1 confers a distinct ligand specificity. Cell Commun Adhes 9:
205–219.
31. Coisne C, Mao W, Engelhardt B (2009) Cutting edge: Natalizumab blocks
adhesion but not initial contact of human T cells to the blood-brain barrier in
vivo in an animal model of multiple sclerosis. J Immunol 182: 5909–5913.
32. Engelhardt B, Kappos L (2008) Natalizumab: targeting alpha4-integrins in
multiple sclerosis. Neurodegener Dis 5: 16–22.
33. Colombel JF, Peyrin-Biroulet L (2006) Natalizumab: a promising treatment for
Crohn’s disease. Expert Rev Clin Immunol 2: 677–689.
34. Edula RG, Picco MF (2009) An evidence-based review of natalizumab therapy
in the management of Crohn’s disease. Ther Clin Risk Manag 5: 935–942.
35. Nguyen K, Sylvain NR, Bunnell SC (2008) T cell costimulation via the integrin
VLA-4 inhibits the actin-dependent centralization of signaling microclusters
containing the adaptor SLP-76. Immunity 28: 810–821.
36. Wang J, Springer TA (1998) Structural specializations of immunoglobulin
superfamily members for adhesion to integrins and viruses. Immunol Rev 163:
197–215.
37. Raymond S, Delobel P, Mavigner M, Cazabat M, Souyris C, et al. (2008)
Correlation between genotypic predictions based on V3 sequences and
phenotypic determination of HIV-1 tropism. Aids 22: F11–16.
38. Schneider H, Canavez FC, Sampaio I, Moreira MA, Tagliaro CH, et al. (2001)
Can molecular data place each neotropical monkey in its own branch?
Chromosoma 109: 515–523.
Polymorphisms in a4 of Neotropical Primates
PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e24461